The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs. It plays a key role in guiding and prioritizing Oncoheroes' research investment.



Peter Adamson, MD, PhD

Chair Children’s Oncology Group

Professor of Pediatrics and Pharmacology, Children’s Hospital of Philadelphia

Patriti Bandopadhayay MBBS, PhD

Pediatric Neuro-Oncologist, Dana Farber Cancer Institute, Boston

Instructor in Pediatrics, Harvard School

Steven Dubois MD, MS

Director Experimental Therapeutics

Dana Farber Cancer Institute, Boston

Associate Professor of Pediatrics, Harvard School


Juliet Gray MD, MA, MB BS, MRCPCH, PhD

Clinical Lead Pediatric Oncology & Hematology Pediatric Oncology Clinical Trials Lead

Southampton Paediatric Oncology Centre


Jaroslav Sterba, MD, PhD

Department of Pediatric Oncology

University Hospital Brno, Czech Republic

Director of the CEPOETA Clinical Network


Lee J. Helman, MD

Professor University of Southern California

Head Basic and Translational Research Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles


Lucas Moreno, MD

Lead Clinical Trials Unit, Children Hospital Niño Jesús, Madrid

Member Clinical Trials Committee ITCC Consortium